Geneoscopy, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.geneoscopy.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)ColoSense Post-Approval Study
Not yet recruiting
- Conditions
- Colorectal Cancer (Diagnosis)
- First Posted Date
- 2025-07-16
- Last Posted Date
- 2025-07-16
- Lead Sponsor
- Geneoscopy, Inc.
- Target Recruit Count
- 12500
- Registration Number
- NCT07069556
Colorectal Cancer and Pre-Cancerous Adenoma Non-Invasive Detection Test Study
Not Applicable
Completed
- Conditions
- Colorectal CancerAdvanced AdenocarcinomaSerrated Polyp
- First Posted Date
- 2021-02-05
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- Geneoscopy, Inc.
- Target Recruit Count
- 14263
- Registration Number
- NCT04739722
- Locations
- 🇺🇸
Geneoscopy, Inc., Saint Louis, Missouri, United States
🇺🇸Elligo Health Research, Austin, Texas, United States
News
No news found